Literature DB >> 17112692

Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats.

Kuntal Maiti1, Kakali Mukherjee, Arunava Gantait, Bishnu Pada Saha, Pulok K Mukherjee.   

Abstract

A novel formulation of curcumin in combination with the phospholipids was developed to overcome the limitation of absorption and to investigate the protective effect of curcumin-phospholipid complex on carbon tetrachloride induced acute liver damage in rats. The antioxidant activity of curcumin-phospholipid complex (equivalent of curcumin 100 and 200 mg/kg body weight) and free curcumin (100 and 200 mg/kg body weight) was evaluated by measuring various enzymes in oxidative stress condition. Curcumin-phospholipid complex significantly protected the liver by restoring the enzyme levels of liver glutathione system and that of superoxide dismutase, catalase and thiobarbituric acid reactive substances with respect to carbon tetrachloride treated group (P < 0.05 and <0.01). The complex provided better protection to rat liver than free curcumin at same doses. Serum concentration of curcumin obtained from the complex (equivalent to 1.0 g/kg of curcumin) was higher (Cmax 1.2 microg/ml) than pure curcumin (1.0 g/kg) (Cmax 0.5 microg/ml) and the complex maintained effective concentration of curcumin for a longer period of time in rat serum. The result proved that curcumin-phospholipid complex has better hepatoprotective activity, owe to its superior antioxidant property, than free curcumin at the same dose level.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17112692     DOI: 10.1016/j.ijpharm.2006.09.025

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  108 in total

1.  Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice.

Authors:  Liu Zhongfa; Ming Chiu; Jiang Wang; Wei Chen; Winston Yen; Patty Fan-Havard; Lisa D Yee; Kenneth K Chan
Journal:  Cancer Chemother Pharmacol       Date:  2011-10-04       Impact factor: 3.333

2.  Anti-inflammatory Effect and Toxicology Analysis of Oral Delivery Quercetin Nanosized Emulsion in Rats.

Authors:  Gabriela Hädrich; Gustavo Richter Vaz; Michelle Maidana; Jadel Muller Kratz; Gecioni Loch-Neckel; Daniely Cornélio Favarin; Alexandre de Paula Rogerio; Flávio Manoel Rodrigues da Silva; Ana Luiza Muccillo-Baisch; Cristiana Lima Dora
Journal:  Pharm Res       Date:  2015-12-18       Impact factor: 4.200

3.  Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Mary Bebawy; Frederick Luk; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

4.  Phytophospholipid Complex of Caffeic Acid: Development, In vitro Characterization, and In Vivo Investigation of Antihyperlipidemic and Hepatoprotective Action in Rats.

Authors:  Shubhada Mangrulkar; Pranav Shah; Sonali Navnage; Priyanka Mazumdar; Dinesh Chaple
Journal:  AAPS PharmSciTech       Date:  2021-01-06       Impact factor: 3.246

5.  Promoted Antitumor Activity of Myricetin against Lung Carcinoma Via Nanoencapsulated Phospholipid Complex in Respirable Microparticles.

Authors:  Noha Nafee; Dina M Gaber; Ahmed O Elzoghby; Maged W Helmy; Osama Y Abdallah
Journal:  Pharm Res       Date:  2020-04-14       Impact factor: 4.200

Review 6.  Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases.

Authors:  Bharat B Aggarwal; Kuzhuvelil B Harikumar
Journal:  Int J Biochem Cell Biol       Date:  2008-07-09       Impact factor: 5.085

7.  Preparation, characterization and in vivo evaluation of bergenin-phospholipid complex.

Authors:  Xuan Qin; Yang Yang; Ting-ting Fan; Tao Gong; Xiao-ning Zhang; Yuan Huang
Journal:  Acta Pharmacol Sin       Date:  2009-12-07       Impact factor: 6.150

8.  Management of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-term follow-up.

Authors:  Pia Allegri; Antonio Mastromarino; Piergiorgio Neri
Journal:  Clin Ophthalmol       Date:  2010-10-21

Review 9.  Molecular targets of curcumin for cancer therapy: an updated review.

Authors:  Pandima Devi Kasi; Rajavel Tamilselvam; Krystyna Skalicka-Woźniak; Seyed Fazel Nabavi; Maria Daglia; Anupam Bishayee; Hamidreza Pazoki-Toroudi; Seyed Mohammad Nabavi
Journal:  Tumour Biol       Date:  2016-07-28

Review 10.  Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases.

Authors:  Avijit Sarkar; Ronita De; Asish K Mukhopadhyay
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.